NEUREN PHARMACEUTICALS LIMITED earnings per share and revenue

NEU earnings per share for the last semiannual are 1.02 AUD whereas the estimation was 1.04 AUD which accounts for -1.30% surprise. Company revenue for the same period amounts to 192.50 M AUD despite the estimated figure of 184.11 M AUD. Estimated earnings per share for the next semiannual are 0.07 AUD, and revenue is expected to reach 30.95 M AUD. Also watch annual changes over time to get a bigger picture of NEU earnings per share and revenue dynamics.